Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stockwatch: Lilly And GW Move Goalposts

This article was originally published in Scrip

Executive Summary

There were few bright spots last week in life sciences, with the NASDAQ Biotech Index finishing down by 4% as it continued, uncharacteristically, to underperform the broad S&P 500 index. The handful of positive announcements from the industry actually look very fragile on closer inspection, perhaps marking new lows for an industry where the integrity of clinical trial announcements and investment bank analysis can no longer be believed in.


Related Content

Stockwatch: The TIGER That Came To Lilly





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts